Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis
AUTOR(ES)
Hennenberg, M
FONTE
Blackwell Publishing Ltd
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2697813Documentos Relacionados
- Structural aspects of the liver in patients with biliary disease and portal hypertension.
- The diameter of the originating vein determines esophageal and gastric fundic varices in portal hypertension secondary to posthepatitic cirrhosis
- Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
- Naturally‐occurring regulatory T cells are increased in inflamed portal tracts with cholangiopathy in primary biliary cirrhosis
- Plasma Volume in Cirrhosis of the Liver: Its Relation of Portal Hypertension, Ascites, and Renal Failure*